Clariane's Shares Jump 3.55% Ahead of Key Release on April 23
Clariane's stock shows a notable increase this Wednesday at midday, rising 3.55% to €3.904. This rebound comes after a nearly stable week, marked by a slight decline of 0.41% over seven days. The price has once again crossed the threshold of its 50-day moving average, in a context of a rising Parisian market, with the CAC 40 up 0.89% during the session.
By establishing itself at €3.904, Clariane has moved above its 50-day moving average (MM50), located at €3.88. This crossing is a technical signal monitored by operators, especially since the stock has been trading close to this level in recent sessions. The RSI, a momentum indicator, is positioned at 52, indicating a balanced situation without excessive buying or selling. The nearest resistance is at €4.07, a threshold nearly coinciding with the upper Bollinger band (€4.06). The 200-day moving average, at €4.18, remains significantly above the current price, indicating that the long-term trend is still weak: over one year, the stock is still down by 7.36%. However, the performance over three months is positive, at +7.79%, signaling a gradual improvement since the beginning of the year.
Upcoming Calendar and Potential Impact
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The schedule for the coming weeks could fuel interest in the stock. Clariane is set to publish its first quarter 2026 revenue on April 23, followed by the annual general meeting scheduled for May 12. These two events will allow an assessment of the operational trajectory of the group specializing in retirement homes and care facilities, after several quarters dedicated to restructuring its balance sheet. The stock operates in an environment of monthly volatility measured at 13.86%, while its negative beta of -0.15 indicates a low correlation with general market movements. This defensive profile distinguishes Clariane within the SBF 120, which is up 0.93% in session this Wednesday. The April quarterly publication will be a crucial element to confirm or refute the recent price dynamics.
Long-term Outlook and Strategic Moves
Despite recent positive short-term indicators, Clariane's long-term perspective remains cautious due to its past performance. The strategic focus on restructuring and the upcoming financial disclosures are critical to gaining investor confidence and determining the future direction of the stock. Market analysts emphasize the importance of the April revenue release and the May general meeting in shaping the market's perception and expectations for Clariane.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: S1 2026
Key reported figures
Revenue: 2 699 millions d'euros
Quarterly revenue: 2 699 millions d'euros
Revenue growth: 1,6 %
EBITDA: 524 millions d'euros
EBITDA margin: 10,4 %
Net income: -47,5 millions d'euros
Free cash flow: 20 millions d'euros
3 020 millions d'euros
Guidance from the release
Le Groupe s'appuiera principalement sur la poursuite de l'amélioration de la performance opérationnelle et le maintien d'une stricte discipline d'investissements
Risks mentioned
Environnement géopolitique complexe affectant les opérations de refinancement
Exposition aux épisodes climatiques frappant durement certains territoires en Europe
Pression inflationniste continue sur les coûts opérationnels malgré les gains tarifaires
Opportunities identified
Amélioration de la marge EBITDA de 100-150 points de base d'ici fin 2026
Croissance des volumes d'activité portée par l'augmentation progressive des taux d'occupation
Refinancement réussi de €1 063m renforçant la flexibilité financière et réduisant le coût de la dette
Outlook / guidance
Expected revenue: 5 522 millions d'euros
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
